Citadel Advisors’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147K | Buy |
+474,094
| New | +$147K | ﹤0.01% | 5123 |
|
|
2025
Q1 | – | Sell |
-727,626
| Closed | -$623K | – | 5914 |
|
|
2024
Q4 | $623K | Buy |
727,626
+374,143
| +106% | +$320K | ﹤0.01% | 3767 |
|
|
2024
Q3 | $3M | Buy |
353,483
+277,030
| +362% | +$2.35M | ﹤0.01% | 2162 |
|
|
2024
Q2 | $357K | Buy |
76,453
+73,344
| +2,359% | +$343K | ﹤0.01% | 4137 |
|
|
2024
Q1 | $21.1K | Sell |
3,109
-74,503
| -96% | -$507K | ﹤0.01% | 5537 |
|
|
2023
Q4 | $260K | Buy |
77,612
+77,239
| +20,708% | +$259K | ﹤0.01% | 4365 |
|
|
2023
Q3 | $929 | Sell |
373
-8,158
| -96% | -$20.3K | ﹤0.01% | 5700 |
|
|
2023
Q2 | $10.9K | Buy |
+8,531
| New | +$10.9K | ﹤0.01% | 5365 |
|
|
2023
Q1 | – | Sell |
-374
| Closed | -$284 | – | 5889 |
|
|
2022
Q4 | $284 | Buy |
+374
| New | +$284 | ﹤0.01% | 5972 |
|
|
2022
Q3 | – | Sell |
-78,843
| Closed | -$75K | – | 5838 |
|
|
2022
Q2 | $75K | Buy |
78,843
+62,158
| +373% | +$59.1K | ﹤0.01% | 5388 |
|
|
2022
Q1 | $35K | Buy |
16,685
+6,027
| +57% | +$12.6K | ﹤0.01% | 6013 |
|
|
2021
Q4 | $95K | Buy |
+10,658
| New | +$95K | ﹤0.01% | 5929 |
|
|
2021
Q3 | – | Sell |
-13,119
| Closed | -$273K | – | 6351 |
|
|
2021
Q2 | $273K | Buy |
+13,119
| New | +$273K | ﹤0.01% | 5299 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6232 |
|
|
2020
Q3 | – | Sell |
-63,322
| Closed | -$2.29M | – | 4642 |
|
|
2020
Q2 | $2.29M | Buy |
63,322
+22,630
| +56% | +$818K | ﹤0.01% | 2124 |
|
|
2020
Q1 | $1.33M | Buy |
+40,692
| New | +$1.33M | ﹤0.01% | 2591 |
|